SPYGLASS PHARMA, INC.

SpyGlass Pharma, Inc.

Equities

SGP

US85220G1094

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 12/03/2026 am IST			5-day change	1st Jan Change
27.10 ^USD	+1.04%		+1.57%	-

10/03	HC Wainwright Initiates SpyGlass Pharma at Buy With $37 Price Target	MT
09/03	SpyGlass Says Phase 1/2 Trial of BIM-IOL System Shows Patients Achieve Decrease in Intraocular Pressure	MT

SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to NASDAQ Composite Index

Published on 02/09/2026 at 04:36 pm IST

S&P Capital IQ

SPYGLASS PHARMA, INC.

+1.04%

+0.03%

NASDAQ COMPOSITE

+0.08%

-0.08%

SpyGlass Pharma, Inc added to NASDAQ Composite Index.

© S&P Capital IQ - 2026

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	SPYGLASS PHARMA, INC.	27.10USD	+1.04%	+1.57%	90Cr
	NASDAQ 100	24,965.01PTS	+0.03%	-0.51%	-
	NASDAQ COMPOSITE	22,716.13PTS	+0.08%	-0.40%	-
	S&P 500	6,775.80PTS	-0.08%	-1.36%	-

Latest news about SpyGlass Pharma, Inc.

10/03	HC Wainwright Initiates SpyGlass Pharma at Buy With $37 Price Target	MT
09/03	SpyGlass Says Phase 1/2 Trial of BIM-IOL System Shows Patients Achieve Decrease in Intraocular Pressure	MT
09/03	SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results For Its Innovative BIM-IOL System	CI
03/03	Leerink Initiates SpyGlass Pharma at Outperform With $42 Price Target	MT
03/03	Stifel Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
03/03	Citigroup Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
03/03	Leerink Initiates at Outperform With $42 Price Target	MT
03/03	Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target	MT
23/02	Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO	RE
12/02	Spyglass Pharma Insider Bought Shares Worth $5,000,000, According to a Recent SEC Filing	MT
10/02	SpyGlass Pharma Closes $172.5 Million IPO	MT
10/02	Spyglass Pharma, Inc. Appoints Habib Dable to the Board of Directors, Effective February 5, 2026	CI
09/02	SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to NASDAQ Composite Index	CI
06/02	SpyGlass Pharma Shares Rise in Nasdaq Debut	MT
06/02	SpyGlass Pharma Prices $150 Million IPO	MT

Chart SpyGlass Pharma, Inc.

Duration

Period

Chart SpyGlass Pharma, Inc.

SGP: Dynamic Chart

Company Profile

Employees

32

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

27.10USD

Average target price

45.00USD

Spread / Average Target

+66.05%

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stock Market News
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to NASDAQ Composite Index

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW